Sign inJoin waitlistJoin the waitlist

Elena Ratner

Co-Founder and Director, Yale Medicine Sexual, Intimacy and Menopause Program · Yale Medicine

Credentials: · · · · ·

History

Yale Medicine Sexual
Present
Section of Gynecologic Oncology · Yale School of Medicine
Present
Discovery to Cure · Yale Univ Sch of Med
Present

Yale University School of Management
2021
Obstetrics and Gynecology
Stony Brook Medicine
2010–2014
Yale Univ Sch of Med
2006–2010
Gynecologic Oncology
Yale Univ Sch of Med
2007–2010
Yale-New Haven Hospital
2004–2007
State University of NY Medical College
2000–2003
Barnard College - Columbia University
1998

Research

Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 587 citations
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk
Cancer Research · 2008 · 535 citations
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor…
Journal of Clinical Oncology · 2018 · 400 citations

Alessandro Santin
104 papers
Masoud Azodi
87 papers
PS
Peter Schwartz
84 papers
Dan-Arin Silasi
59 papers · 5 as a fellow
Natalia Buza
58 papers · 5 as a fellow
Gary Altwerger
54 papers · 49 as a resident
Pei Hui
54 papers
GM
Gulden Menderes
40 papers · 11 as a fellow
GH
Gloria Huang
37 papers
Thomas Rutherford
37 papers
Jonathan Black
28 papers · 24 as a fellow
Babak Litkouhi
25 papers

Clinical trials

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Site PI · Recruiting · Phase 3
GOG Foundation
2024–2034
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Site PI · Unknown · Phase 3
Gynecologic Oncology Group
2012